ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 58 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,000 | 0.0% | 1,619 | +1.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,603 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 1,603 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 1,603 | -5.0% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 1,687 | +1.7% | 0.00% | – |
| Q1 2016 | $1,000 | -75.0% | 1,658 | -54.7% | 0.00% | – |
| Q4 2015 | $4,000 | -92.3% | 3,658 | -84.1% | 0.00% | – |
| Q3 2015 | $52,000 | +4.0% | 23,052 | +7.5% | 0.00% | – |
| Q2 2015 | $50,000 | +8.7% | 21,449 | -0.1% | 0.00% | – |
| Q1 2015 | $46,000 | -6.1% | 21,465 | +0.1% | 0.00% | – |
| Q4 2014 | $49,000 | -14.0% | 21,449 | 0.0% | 0.00% | – |
| Q3 2014 | $57,000 | -78.1% | 21,449 | -69.3% | 0.00% | – |
| Q2 2014 | $260,000 | -14.5% | 69,884 | +170.1% | 0.00% | – |
| Q1 2014 | $304,000 | +37.6% | 25,874 | -2.5% | 0.00% | – |
| Q4 2013 | $221,000 | -10.5% | 26,545 | -0.0% | 0.00% | – |
| Q3 2013 | $247,000 | -3.5% | 26,546 | +1.5% | 0.00% | – |
| Q2 2013 | $256,000 | – | 26,166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|